T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Waste Management
WM
$90.1B
| $35.8M | 0.01% |
697,821
-4,180
| -0.6% | -$204K |
|
|
SFE
952
DELISTED
Safeguard Scientifics, Inc.
SFE
| $35.8M | 0.01% |
1,804,663
-23,800
| -1% | -$459K |
|
953
Ventas
VTR
$46.3B
| $35.6M | 0.01% |
434,888
+12,356
| +3% | +$975K |
|
954
Edison International
EIX
$27.3B
| $35.5M | 0.01% |
542,563
+30
| +0% | +$1.86K |
|
955
Entegris
ENTG
$25.2B
| $35.5M | 0.01% |
2,688,902
-425,050
| -14% | -$5.45M |
|
|
DWA
956
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $35.5M | 0.01% |
1,589,100
+740,100
| +87% | +$16.7M |
|
957
Fossil Group
FOSL
$332M
| $35.5M | 0.01% |
320,367
-28,315
| -8% | -$2.96M |
|
958
STRATTEC Security
STRT
$341M
| $35.5M | 0.01% |
429,603
-21,331
| -5% | -$1.99M |
|
|
CGI
959
DELISTED
Celadon Group Inc
CGI
| $35.3M | 0.01% |
1,557,296
-451,484
| -22% | -$9.43M |
|
|
VALE.P
960
DELISTED
Vale S A
VALE.P
| $35.1M | 0.01% |
4,834,596
-181,330
| -4% | -$1.47M |
|
|
GNMK
961
DELISTED
GenMark Diagnostics, Inc
GNMK
| $35M | 0.01% |
2,568,754
-18,000
| -0.7% | -$201K |
|
962
Applied Industrial Technologies
AIT
$13.1B
| $34.9M | 0.01% |
765,502
-2,900
| -0.4% | -$135K |
|
963
T. Rowe Price
TROW
$23.5B
| $34.8M | 0.01% |
404,994
-4,200
| -1% | -$342K |
|
|
TXTR
964
DELISTED
TEXTURA CORPORATION COM
TXTR
| $34.5M | 0.01% |
1,213,000
+44,000
| +4% | +$1.12M |
|
965
Quanex
NX
$985M
| $34.5M | 0.01% |
1,834,933
-773,257
| -30% | -$14.8M |
|
966
Hope Bancorp
HOPE
$1.84B
| $34.3M | 0.01% |
2,383,540
+731,440
| +44% | +$10.3M |
|
967
FRP Holdings
FRPH
$426M
| $34.2M | 0.01% |
1,744,860
-28,140
| -2% | -$533K |
|
968
TETRA Technologies
TTI
$1.29B
| $34.2M | 0.01% |
5,119,000
-2,009,670
| -28% | -$16M |
|
969
Saga Communications
SGA
$62.1M
| $34.1M | 0.01% |
784,843
| – | – |
|
970
Public Service Enterprise Group
PEG
$37.8B
| $34.1M | 0.01% |
823,246
+3,620
| +0.4% | +$146K |
|
|
GTS
971
DELISTED
Triple-S Management Corporation
GTS
| $33.9M | 0.01% |
1,491,289
-24,806
| -2% | -$529K |
|
|
BLCM
972
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $33.9M | 0.01% |
+151,165
| New | +$32.4M |
|
|
INFA
973
DELISTED
INFORMATICA CORP
INFA
| $33.7M | 0.01% |
884,080
+25,386
| +3% | +$912K |
|
974
Murphy USA
MUSA
$10.2B
| $33.6M | 0.01% |
488,283
+317,228
| +185% | +$18.8M |
|
975
Zimmer Biomet
ZBH
$18.8B
| $33.4M | 0.01% |
303,145
+9,980
| +3% | +$1.05M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.